Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 19/20 | 0.55 |
| ▸ | RARG | P13631 | 5/20 | 0.55 |
| ▸ | RARB | P10826 | 4/20 | 0.55 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.39 |
| ▸ | RXRB | P28702 | 5/20 | 0.37 |
| ▸ | RXRG | P48443 | 5/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7755796 | 1.00 | RXRA (0.55) | RXRARARGRARBCYP26A1RXRB | |
| SCHEMBL7755781 | 1.00 | RXRA (0.55) | RXRARARGRARBCYP26A1RXRB | |
| SCHEMBL7755829 | 0.92 | RXRA (0.60) | RXRARARGRARBCYP26A1RXRB | |
| SCHEMBL7755837 | 0.92 | RXRA (0.60) | RXRARARGRARBCYP26A1RXRB | |
| SCHEMBL7755812 | 0.92 | RXRA (0.47) | RXRARARGRARBRXRBRXRG | |
| SCHEMBL7755832 | 0.92 | RXRA (0.60) | RXRARARGRARBCYP26A1RXRB | |
| SCHEMBL7755803 | 0.92 | RXRA (0.47) | RXRARARGRARBRXRBRXRG | |
| SCHEMBL7755808 | 0.92 | RXRA (0.47) | RXRARARGRARBRXRBRXRG | |
| SCHEMBL7755791 | 0.92 | RXRA (0.49) | RXRARARGRARBRXRBRXRG | |
| SCHEMBL7757702 | 0.75 | RXRA (0.45) | RXRARARGRARBCYP26A1RXRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1077920-A1 | NEW COMPOUNDS, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 2001-02-28 | — | — | EP | disclosed |
| WO-1999058487-A1 | NEW COMPOUNDS, THEIR PREPARATION AND USE | NOVO NORDISK A/S (DK) | 1999-11-18 | — | — | WO | disclosed |